Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
2
×
biotech
breast cancer
immunotherapy
life sciences
national blog main
pfizer
san diego blog main
san diego top stories
abbvie
adverum biotechnologies
albert bourla
alzheimer's disease
american cancer society
amicus therapeutics
arvinas
avelumab
batten disease
bayer
big pharma
biogen
biovex
boehringer ingelheim
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
brian stuglik
cancer
cancer diagnostics
cancer immunotherapy
casimir trials
celenex
checkpoint inhibitor
chemotherapy
christine mcsherry
chuck schumer
city hill ventures
clinial trials
crispr therapeutics
What
bio
pfizer
2
×
acquisitions
albert
approved
biggest
bourla
cancer
ceo
combo
companies
company
crispr
dating
drug
future
game
happening
immunotherapies
imports
kgaa
maker
maps
measured
medications
merck
oncolytics
patients
pfizer’s
pharmaceutical
revenue
roundup
sorts
speed
study
tacks
testing
there’s
today
world’s
Language
unknown
Current search:
pfizer
×
amgen
×
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
4 years ago
Oncolytics Bio Tacks On Cancer Combo Study with Merck KGaA, Pfizer